期刊文献+

中西医结合法逆转人结肠癌多药耐药的实验研究

Experimental study of integrated traditional clinese and western medicine reverse multidrug resistance in humancolon cancer
下载PDF
导出
摘要 目的探讨中西医结合方法逆转人结肠癌耐药株多药耐药的机制。方法用四甲基偶氮唑蓝(MTT)法测定5-氟尿嘧啶(5-Fu)对实验组及对照组细胞的细胞毒作用,测定其半数抑制浓度,计算其逆转倍数(RI),并用流式细胞仪测定细胞内罗丹明的滞留浓度,分析P-糖蛋白的滞留浓度。结果中西医结合法可以明显增加化学治疗药物对结肠癌耐药细胞的杀伤作用(P<0.05),逆转了其多药耐药作用,逆转指数为2.92,并减少了P-糖蛋白对化学治疗药物的外排。结论中西医结合法对结肠癌多药耐药逆转效果明显,其机制可能与其中药成分抑制P-糖蛋白的外排作用有关,值得进一步研究开发。 Objective To investigate the combined method of reversing human colon cancer resistant strains muhidrug resistance mechanism of traditional Chinese medicine and Western medicine. Methods To determine the 5-FU of the experimental group and the control group cell cytotoxicity by MTT method, determination of the half inhibitory concentration, the reversal index calculation, and determination of intracellular Rhodamine flow cytometry retention con- centration, namely stranded concentration P-glycoprotein. Results The traditional Chinese and Western medicine can significantly increased the killing effect of chemotherapy drugs on colon cancer drug-resistant cell (P〈0.05), reversed the multi-drug resistance, reversal index was 2.92, and could reduce the P glycoprotein on the efflux of chemotherapeutic drugs. Conclusion Traditional Chinese and Western Medicine on colon cancer muhidrug resistance reversal effect, its mechanism may be associated with traditional Chinese medicine compositions to inhibit P-glycoprotein efflux effect, worthy of further research and development.
作者 高斌
出处 《实用医技杂志》 2013年第8期827-828,共2页 Journal of Practical Medical Techniques
关键词 P糖蛋白类 多药耐药相关蛋白质类 逆转录作用 P-glycoprotein Muhidrug iated proteins Reverse transcription
  • 相关文献

参考文献8

  • 1Rossd D.Novel mechanisms of drug resistance in leukemia.Leu-kemia,2000,14(3):467-473.
  • 2Liscovitch M,Lavie Y.Cancer multidrug resistance:a review of recent drug discovery research.I Drugs,2002,5(4):349-355.
  • 3Bates S,Kang M,Meadows B,et al.A phase Ⅰ study of infu-sional vinblastine in combination with the P-glycoprotein antag-onist PSC 833(valspodar).Cancer,2001,92(6):1577-1590.
  • 4Dantzig AH,Sheopard RL,Law KL,et al.Selectivity of the multidrug resistance modulator,LY335979,for P-glycoprotein and effect on cytochrome P-450 activities.J Pharmacol Exp Ther,1999,290(2):854-862.
  • 5Morschharser F,Zinzanip L,Burgess M,et al.PhaseⅠ/Ⅱ trial of a P-glycoprotein inhibitor,Zosuquidar.3HCl trihydrochloride (LY335979),given orally in combination with the CHOP regi-men in patients with non-Hodgkins lymphoma.Leuk Lymphoma,2007,48(4):708-715.
  • 6王利,唐宗山,黄宗干,王亚平.人参总皂甙逆转K562/A02细胞对DOX耐药性的研究[J].重庆医科大学学报,2003,28(4):424-427. 被引量:12
  • 7Chieli E,Santoni-Rugiu E,Cervelli F,et al.Differential modu-lation of P-glycoprotein expression by dexamethasone and 3-methylcholan-threne in rathepatocyte primary cultures.Carcino-genesis,1994,15(2):335.
  • 8张霆钧,高翠华,张莉芳,王熙才,韩复生.阿霉素在小鼠体内诱导S-180细胞株抗药性的实验研究[J].实用肿瘤杂志,1994,9(2):102-105. 被引量:11

二级参考文献15

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2潘启超,田晖.多种中药单体逆转肿瘤多药耐药性[J].科学通报,1995,40(20):1901-1904. 被引量:69
  • 3李羲,郭先健,钱桂生,李淑平.人肺腺癌细胞系中P─糖蛋白表达与抗药程度的关系[J].第三军医大学学报,1996,18(6):534-535. 被引量:5
  • 4Flens MJ, Zamsn GJR, Van der valk P, et al. Tissue distribution of multidrug resistance protein[J]. Am J Pathol, 1996;148(4):1237-1247.
  • 5Futscher BW, Foley NE, Gleason - Guzman MC, et al.Verapamil suppresses the emergence of P - glycoprotein - mediated multi- drug resistance[ J ]. Int J Cancer, 1996;66 (4) :520- 525.
  • 6Allikmets R,Schriml LM,Hutchinson A,et al. A human placenta- specific ATP - binding cassette gene (ABCP) on chromosome 4q22 that is involved :in multidrug resistance[J].Cancer Res, 1998;58 (23):5337-5339.
  • 7Reed JC. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies [ J ]. Semin Hematol, 1997; 34 (4 suppl5) :9- 19.
  • 8Sonneveld P. Multidrug resistance in haematological malignancies[J]. J Intern Med,2000;247(5) :521 - 534.
  • 9Scholtoma JM, Romijn JC, van Stoenbruggo GJ, et al.Inhibition of apoptotic proteins cause multidrug resistance in renal carcinoma cells [ J ]. Anticancer Res, 2001 ; 21 ( 5 ) : 3161 -3166.
  • 10Consoli U, Santonocito A, Stagno F, et al. Multidrug resistance mechanisms in chronic lymphocytic leukaemia[J ]. Br J Haematol, 2002 ; 116 (4) : 774 - 780.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部